Meeting of the Advisory Committee on Infant and Maternal Mortality (Formerly the Advisory Committee on Infant Mortality), 66198-66199 [2022-23790]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 211 / Wednesday, November 2, 2022 / Notices
accepted by HRSA, the Bright Futures
Periodicity Schedule is part of the
HRSA-supported preventive service
guidelines for infants, children, and
adolescents. The development of the
Periodicity Schedule is maintained
through a national cooperative
agreement, the Bright Futures Pediatric
Implementation Program, with AAP.
Under Section 2713 of the Public Health
Service Act (42 U.S.C. 300gg–13) and
pertinent regulations, non-grandfathered
group health plans and health insurance
issuers must provide coverage, without
cost sharing, for certain preventive
services for plan years (in the individual
market, policy years) that begin on or
after the date that is 1 year after the date
the recommendation or guideline is
issued. These include HRSA-supported
preventive health services provided for
in the Bright Futures Periodicity
Schedule as part of the HRSA-supported
preventive services guidelines for
infants, children, and adolescents.
Through the cooperative agreement
with the AAP, the Bright Futures
Pediatric Implementation Program is
required to administer a process for
developing and regularly
recommending, as needed, updates to
the Bright Futures Periodicity Schedule
through a process that includes a
comprehensive, objective, and
transparent review of available evidence
that incorporates opportunity for public
comment. Accordingly, the Program
reviews the evidence to determine
whether updates are needed, develops
recommended updates, seeks and
considers public comments, and makes
recommendations to HRSA.
The AAP convenes a panel of
pediatric primary care experts, the
Bright Futures Periodicity Schedule
Working Group, to review the latest
evidence, develop draft recommended
updates, seek and consider public
comment, and propose updates to the
Bright Futures Periodicity Schedule.
Comments received from the public will
be reviewed and discussed by the Bright
Futures Periodicity Schedule Working
Group.
TOPIC
ADOLESCENCE
PROCEDURES
HIV (CUmmt) :io
khammond on DSKJM1Z7X2PROD with NOTICES
HIV (Proposed)'°
11Y 12Y 13Y 14Y 1SY 16Y 17Y 18Y 19Y 20Y 21 Y
•
.
* * * * .
* * * * •
All such screenings (universal and
risk-based) within this age range are
within the scope of the guideline. The
proposed update also includes an
accompanying footnote to provide
updated information from the AAP
about more frequent screening for youth
assessed as at high risk of HIV infection.
The full footnote reads:
Authority: 2713(a)(3) of the Public
Health Service Act, 42 U.S.C. 300gg–
13(a)(3).
‘‘Screen adolescents for HIV at least once
between the ages of 15 and 21 making every
effort to preserve confidentiality of the
adolescent, as per ‘‘Human
Immunodeficiency Virus (HIV) Infection:
Screening’’ (https://www.uspreventive
servicestaskforce.org/uspstf/
recommendation/human-immunodeficiencyvirus-hiv-infection-screening), and after
initial screening, youth at increased risk of
HIV infection should be retested annually or
more frequently, as per ‘‘Adolescents and
Young Adults: The Pediatrician’s Role in HIV
Testing and Pre- and Postexposure HIV
Prophylaxis’’ (https://doi.org/10.1542/
peds.2021-055207).’’
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
16:38 Nov 01, 2022
Jkt 259001
The proposed update to the Bright
Futures Periodicity Schedule would
indicate that the recommended age
range for which adolescents may be
provided universal screening for HIV is
between the 15-year visit and 21-year
visit. In the current Bright Futures
Periodicity Schedule, the age range
recommended for which adolescents
may be offered universal screening for
HIV is between the 15-year visit and 18year visit. Early detection of an infection
with HIV in adolescents and young
adults can lead to improved health
outcomes and reduce the further spread
of HIV by individuals who are not yet
aware they are infected. Universal
screening is a type of screening that a
provider may recommend without first
identifying a specific risk factor or
symptom.
The current and proposed update to
HIV screening is reflected in the chart
below:
--+
Carole Johnson,
Administrator.
[FR Doc. 2022–23845 Filed 11–1–22; 8:45 am]
December 7, 2022, from 11 a.m.
to 6 p.m. Eastern Time.
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Infant and Maternal Mortality (Formerly
the Advisory Committee on Infant
Mortality)
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Infant and Maternal
Mortality (ACIMM or Committee) has
SUMMARY:
Frm 00072
Fmt 4703
scheduled a public meeting. Information
about ACIMM and the agenda for this
meeting can be found on the ACIMM
website at https://www.hrsa.gov/
advisory-committees/infant-mortality/
index.html.
DATES:
BILLING CODE 4165–15–P
PO 00000
* * *
Sfmt 4703
This meeting will be held
via webinar. The webinar link and login information will be available at the
ACIMM website before the meeting:
https://www.hrsa.gov/advisorycommittees/infant-mortality/.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Vanessa Lee, MPH, Designated Federal
Officer, Maternal and Child Health
Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, Maryland
20857; 301–443–0543; or SACIM@
hrsa.gov.
ACIMM is
authorized by section 222 of the Public
Health Service Act (42 U.S.C. 217a), as
amended. The Committee is governed
by provisions of Public Law 92–463, as
amended, (5 U.S.C. App. 2), which sets
SUPPLEMENTARY INFORMATION:
E:\FR\FM\02NON1.SGM
02NON1
EN02NO22.001</GPH>
66198
66199
Federal Register / Vol. 87, No. 211 / Wednesday, November 2, 2022 / Notices
forth standards for the formation and
use of Advisory Committees.
The ACIMM advises the Secretary of
Health and Human Services (Secretary)
on department activities, partnerships,
policies, and programs directed at
reducing infant mortality, maternal
mortality and severe maternal
morbidity, and improving the health
status of infants and women before,
during, and after pregnancy. The
Committee provides advice on how to
coordinate federal, state, local, tribal,
and territorial governmental efforts
designed to improve infant mortality,
related adverse birth outcomes,
maternal health, as well as influence
similar efforts in the private and
voluntary sectors. The Committee
provides guidance and
recommendations on the policies,
programs, and resources required to
address the disparities and inequities in
infant mortality, related adverse birth
outcomes and maternal health
outcomes, including maternal mortality
and severe maternal morbidity. With its
focus on underlying causes of the
disparities and inequities seen in birth
outcomes for women and infants, the
Committee advises the Secretary on the
health, social, economic, and
environmental factors contributing to
the inequities and proposes structural,
policy, and/or systems level changes.
The agenda for the December 7, 2022,
meeting is being finalized and may
include the following topics: a review of
draft recommendations for the Secretary
on improving birth outcomes among
American Indian and Alaska Native
mothers and infants and a vote on
whether to send them forward;
discussion to determine new and
continuing priority areas for the
Committee; and Committee operations.
Agenda items are subject to change as
priorities dictate. Refer to the ACIMM
website listed above for any updated
information concerning the meeting.
Members of the public will have the
opportunity to provide written or oral
comments. Requests to submit a written
statement or make oral comments to
ACIMM should be sent to Vanessa Lee,
using the email address above at least 3
business days prior to the meeting.
Public participants may submit written
statements in advance of the scheduled
meeting by emailing SACIM@hrsa.gov.
Oral comments will be honored in the
order they are requested and may be
limited as time allows.
Individuals who plan to attend and
need special assistance or a reasonable
accommodation should notify Vanessa
Lee at the contact information listed
above at least 10 business days prior to
the meeting.
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Abstract: The Office for Civil Rights is
seeking a revision on an approval for a
3-year clearance on a previous
collection. Individuals may file written
or electronic complaints with the Office
for Civil Rights when they believe they
have been discriminated against by
programs or entities that receive Federal
financial assistance from the Health and
Human Service or if they believe that
their right to the privacy of protected
health information freedom has been
violated. Annual Number of
Respondents frequency of submission is
record keeping and reporting on
occasion.
Title of the Collection: Assurance of
Compliance, Form HHS–690.
Type of Collection: Revision.
OMB No. 0945–0008.
Abstract: This Information Collection
Request is to continue the previously
approved collection 0945–0008 that is
expiring in December 2022, titled:
Assurance of Compliance, Form HHS–
690, subject to minor modifications.
Such an assurance is required by the
federal civil rights laws enforced by the
Office for Civil Rights, as described
herein. One method that the federal
government uses to ensure civil rights
compliance is to require covered entities
to submit written assurances of
compliance when applying for federal
financial assistance. The assurances
alert covered entities of their civil rights
obligations and provide the Department
with a valuable enforcement tool, as a
recipient’s written assurance and
certification documents can provide an
independent contractual basis for
enforcement of nondiscrimination
requirements.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–23790 Filed 11–1–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier OS–0990–0008]
Agency Information Collection
Request. 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before January 3, 2023.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0008–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, or call (202)
264–0041 the Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden/
response
(in hours)
Number
responses per
respondents
Total burden
hours
Type of respondent
Form name
States, certain health care providers,
other persons and entities.
Form HHS–690 ................................
9595
1
4
38,380
Total ...........................................
...........................................................
........................
........................
........................
38,380
VerDate Sep<11>2014
16:38 Nov 01, 2022
Jkt 259001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 87, Number 211 (Wednesday, November 2, 2022)]
[Notices]
[Pages 66198-66199]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23790]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Infant and Maternal
Mortality (Formerly the Advisory Committee on Infant Mortality)
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Infant and Maternal
Mortality (ACIMM or Committee) has scheduled a public meeting.
Information about ACIMM and the agenda for this meeting can be found on
the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/.
DATES: December 7, 2022, from 11 a.m. to 6 p.m. Eastern Time.
ADDRESSES: This meeting will be held via webinar. The webinar link and
log-in information will be available at the ACIMM website before the
meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal
Officer, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, Maryland 20857; 301-443-0543; or [email protected].
SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee
is governed by provisions of Public Law 92-463, as amended, (5 U.S.C.
App. 2), which sets
[[Page 66199]]
forth standards for the formation and use of Advisory Committees.
The ACIMM advises the Secretary of Health and Human Services
(Secretary) on department activities, partnerships, policies, and
programs directed at reducing infant mortality, maternal mortality and
severe maternal morbidity, and improving the health status of infants
and women before, during, and after pregnancy. The Committee provides
advice on how to coordinate federal, state, local, tribal, and
territorial governmental efforts designed to improve infant mortality,
related adverse birth outcomes, maternal health, as well as influence
similar efforts in the private and voluntary sectors. The Committee
provides guidance and recommendations on the policies, programs, and
resources required to address the disparities and inequities in infant
mortality, related adverse birth outcomes and maternal health outcomes,
including maternal mortality and severe maternal morbidity. With its
focus on underlying causes of the disparities and inequities seen in
birth outcomes for women and infants, the Committee advises the
Secretary on the health, social, economic, and environmental factors
contributing to the inequities and proposes structural, policy, and/or
systems level changes.
The agenda for the December 7, 2022, meeting is being finalized and
may include the following topics: a review of draft recommendations for
the Secretary on improving birth outcomes among American Indian and
Alaska Native mothers and infants and a vote on whether to send them
forward; discussion to determine new and continuing priority areas for
the Committee; and Committee operations. Agenda items are subject to
change as priorities dictate. Refer to the ACIMM website listed above
for any updated information concerning the meeting.
Members of the public will have the opportunity to provide written
or oral comments. Requests to submit a written statement or make oral
comments to ACIMM should be sent to Vanessa Lee, using the email
address above at least 3 business days prior to the meeting. Public
participants may submit written statements in advance of the scheduled
meeting by emailing [email protected]. Oral comments will be honored in
the order they are requested and may be limited as time allows.
Individuals who plan to attend and need special assistance or a
reasonable accommodation should notify Vanessa Lee at the contact
information listed above at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-23790 Filed 11-1-22; 8:45 am]
BILLING CODE 4165-15-P
